The North American Biguanide Drugs Market, valued at $1.36B in 2025, is poised for steady growth driven by rising diabetes prevalence. Explore market trends, key players (Sanofi, Merck, GlaxoSmithKline), and future projections in this comprehensive analysis. Learn about Metformin, Buformin, and Phenformin market segments and regional variations.
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.